Europe Remote Patient Monitoring and Care Market - Industry Trends and Forecast to 2030

Europe Remote Patient Monitoring and Care Market Analysis and Insights

The RPM and care approach to healthcare delivery has become increasingly popular in recent years, particularly due to the COVID-19 pandemic, which has led to an increased demand for remote care options. The increasing awareness about RPM and care globally has enhanced the demand for the market. The rising healthcare expenditure for better health services also contributes to the market growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in the improved technological advancement of devices also contributes to the rising demand for RPM and care.

The Europe remote patient monitoring and care market is expected to grow in the forecast year due to the rise in market players and the availability of advanced remote monitoring devices. Along with this, manufacturers are engaged in the developmental activity for launching novel devices and efficient and accurate RPM products in the market. The increasing development in the field of advanced healthcare techniques is further boosting market growth. However, difficulties such as the stringent regulations for the production and commercialization of RPM and care products are expected to restrain market growth in the forecast period.

Increasing healthcare expenditure on advancement and development is expected to provide opportunities for market growth. However, the high cost of remote monitoring and care devices is expected to pose a challenge to market growth.

Various companies are taking initiatives that gradually lead to market growth.

For instance,

• In January 2023, CoachCare announced that it has acquired Winston-Salem-based RPM company NVOLVE to extend its RPM expertise in the pain, spine, and orthopedic field. This acquisition would help the company in its product portfolio and business expansion.

Data Bridge Market Research analyzes that the Europe remote patient monitoring and care market is expected to reach the value of USD 6,258.62 million by 2030, at a CAGR of 14.2% during the forecast period of 2023-2030.

Market Definition

Remote Patient Monitoring (RPM) and care is a healthcare delivery model that allows healthcare providers to monitor patients remotely, using various technological devices and communication tools, without the need for face-to-face visits. This approach enables healthcare providers to deliver care and track patient health data from a distance, often in real time.

RPM typically involves the use of sensors-enabled wearable devices and other technological devices that can track a patient's vital signs, medication adherence, physical activity, and other health-related information. The collected data is then transmitted to healthcare providers who can analyze the information and take appropriate action, such as adjusting medication dosages, providing guidance on lifestyle changes, or scheduling follow-up appointments.

Europe Remote Patient Monitoring and Care Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:     

Driver

• Increasing Prevalence of Chronic Diseases

The market is expanding due to various causes, including the increasing prevalence of chronic diseases. Chronic diseases are non-communicable illnesses that last long and necessitate continuing medical care and management.

According to the World Health Organization, chronic diseases account for nearly 70% of all deaths worldwide, with cardiovascular disease being the primary cause. The rising prevalence of chronic diseases is increasing due to many variables, including an aging population, sedentary lifestyles, poor nutrition, and environmental factors. RPM and care can help healthcare providers to manage chronic diseases more efficiently and effectively.

As a result of the sedentary lifestyle of people, the prevalence of lifestyle-associated disorders such as hypertension and diabetes witnessed a rise. Thus, the rising prevalence of chronic diseases with the growing integration of healthcare data with portable devices is expected to demand proper health management, leading to the anticipated increasing demand for RPM and care in the market in the forecast period.

Restraint

• Strict Regulatory Framework 

Regulatory bodies play a critical role in ensuring that remote patient monitoring technologies meet safety and quality standards and protect patient privacy. However, regulatory compliance can be a significant barrier to entry for many companies and may slow down the adoption of remote patient monitoring technologies.

The medical device regulations hold significant responsibility for safeguarding the health of the people in the medical device industry itself. The regulations require manufacturers to inculcate quality systems (based on internationally accepted standards for quality systems) into the design process for class III and IV devices. They also require manufacturers to incorporate them into the manufacturing process for class II, III, and IV devices.

Along with such strict regulations of medical devices, it has also been reported that Health Canada’s decision related to medical device applications is not timely. It involves reviewing the submission of scientific evidence by manufacturers to ensure the efficacy of various devices.

This suggests that such a tedious procedure led to the development of other technologically advanced devices and hence, poses a big challenge in front of device manufacturers in submitting the approval documentation.

The regulations imposed would delay the supply of the instrumentation and long-time approval for the devices. This factor is expected to act as a restraint for market growth.

Opportunity

• Strategic Initiatives by Market Players

The strategic initiatives taken by the key market players have helped in the rise in technologies and advancements in remote patient monitoring products and devices. They are taking initiatives such as product launches, collaborations, mergers, and acquisitions among others, which is expected to create more opportunities for market growth.

Healthcare product suppliers have a huge opportunity to work with new technology firms to ensure the industry's continued growth, creativity, and viability.

To discover and develop advanced remote monitoring facilities, companies are launching new initiatives and collaborating with other key players to deliver more reliable results and services.

These strategic initiatives such as product launches, approvals, acquisitions, and mergers done by major companies in the market have opened up an opportunity for companies in various regions. This strategy is allowing the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is expected to provide an opportunity for market growth.

Challenge

• Lack of Skilled Professionals

Remote patient monitoring requires a range of professionals with specialized knowledge and expertise, including clinicians, technicians, and data analysts.

Clinicians are responsible for monitoring patient's health remotely and interpreting the data collected by remote patient monitoring devices.

Moreover, technicians are responsible for installing, maintaining, and troubleshooting remote patient monitoring devices. Data analysts are responsible for analyzing the data collected by remote patient monitoring devices and providing insights to healthcare providers. However, there is currently a shortage of data analysts, clinicians, and technicians with the necessary skills and experience to provide meaningful insights from remote patient monitoring data.

The lack of skilled professionals can also limit the adoption of RPM technologies and limit their potential to improve healthcare outcomes. Without skilled professionals, healthcare providers may struggle to interpret patient data and provide appropriate interventions, limiting the effectiveness of RPM in improving patient outcomes. Thus, the lack of skilled professionals is a significant factor expected to pose a challenge to market growth.

Recent Developments

• In January 2023, Masimo and Philips announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch. This collaboration extension would help the company in remote patient monitoring product portfolio expansion.
• In December 2022, Masimo announced the full market release of the Hydration Index (Hi) for the Masimo W1 watch. The Masimo W1, an advanced health-tracking wearable, is the first watch to offer accurate, continuous pulse oximetry measurements and insightful health data, from the leader in hospital pulse oximetry. This product upgradation would help the company in product business expansion.

Europe Remote Patient Monitoring and Care Market Scope

The Europe remote patient monitoring and care market is segmented into three notable segments such as device type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. 

Device Type

• Cardiac Monitoring Devices
• Blood Pressure Monitoring Devices
• Blood Glucose Monitoring Devices
• Respiratory Monitoring Devices
• Neurologiocal Monitoring Devices
• Multi-Parameter Monitoring Devices
• Others

On the basis of device type, the market is segmented into cardiac monitoring devices, blood pressure monitoring devices, blood glucose monitoring devices, respiratory monitoring devices, neurological monitoring devices, multi-parameter monitoring devices, and others.

Application

• Oncology
• Diabetes
• Cardiovascular Diseases
• Others

On the basis of application, the market is segmented into oncology, diabetes, cardiovascular diseases, and others.

End User

• Hospital-Based Patients
• Ambulatory Patients
• Home Healthcare Patients

On the basis of end user, the market is segmented into hospital-based patients, ambulatory patients, and home healthcare patients.

Europe Remote Patient Monitoring and Care Market Regional Analysis/Insights

The Europe remote patient monitoring and care market is segmented into three notable segments based on device type, application, and end user.

The countries covered in this market report are Germany, France, U.K., Italy, Spain, Belgium, Turkey, Netherlands, Russia, Switzerland, Rest of Europe.

Germany is expected to dominate the  Europe remote patient monitoring and care market due to the increasing demand from emerging markets and expansion.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Remote Patient Monitoring and Care Market Share Analysis

The Europe remote patient monitoring and care market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.

Some of the major market players operating in the Europe remote patient monitoring and care market are Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips N.V., OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera, and Withings among others.

SKU-70102